LogicBio Therapeutics, Inc. Accounts Receivable
LogicBio Therapeutics, Inc. had Accounts Receivable of $30.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-04.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2022-03-04
- 2021-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $30.00K.
- 2021-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $119.00K.
- 2021-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $77.00K; Accounts Receivable, after Allowance for Credit Loss, Current as first filed $89.00K.
- 2020-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $263.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2021-12-31 | $30.00K 10-K · filed 2022-03-04 | |
| 2021-09-30 | $119.00K 10-Q · filed 2021-11-15 | |
| 2021-03-31 | $77.00K 10-Q · filed 2021-08-09 | $89.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $263.00K 10-K · filed 2021-03-15 |